PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2D026F01058511945974!other medical — Eagle Pharmaceuticals, Inc

Eagle Pharmaceuticals, Inc holds $848K across 45 federal awards, concentrated at Department of Defense (DOD). Recompete timing centers on the Apr 6, 2027 PoP end — agencies typically plan 12–18 months ahead.

Dla Troop Support

Awarding office

Eagle Pharmaceuticals, Inc

Recipient

Apr 6, 2027

PoP end

$186K

Obligated

$186K

Potential

325411

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Eagle Pharmaceuticals, Inc — $90

Contract facts

Federal

Contract numberSPE2D026F0105

Also listed asSPE2D0-26-F-0105

Also listed asSPE2D018D0006-SPE2D026F0105

AgencyDla Troop Support

Awarding officeDla Troop Support

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentEagle Pharmaceuticals, Inc

CAGE7LL94

UEIVRQKPMHD3CK7

NAICS325411

No full NAICS 325411 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVSPE2D018D0006

Place of performanceWOODCLIFF LAKE NJ

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startFeb 26, 2026

PoP end (current)Apr 6, 2027

Obligated$186K

Current value$186K

Potential value$186K

8511945974!OTHER MEDICAL is a federal award for Dla Troop Support held by Eagle Pharmaceuticals, Inc. Estimated value $186K ($186K obligated). Current period of performance ends Apr 6, 2027. Place of performance: WOODCLIFF LAKE NJ.

Recompete timing

Public

● Expiring in 211 days

Current PoP ends Apr 6, 2027 (211 days remaining). Agencies typically plan 12–18 months ahead — at 6.9 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Eagle Pharmaceuticals, Inc — $848K obligated across 45 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$848K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract SPE2D026F0105?

SPE2D026F0105 (8511945974!other medical) is a Dla Troop Support award with a potential value of $186K, currently held by Eagle Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2D0-26-F-0105?

SPE2D0-26-F-0105 is the dashed form of PIID SPE2D026F0105 (8511945974!other medical), held by Eagle Pharmaceuticals, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2D026F0105?

Dla Troop Support awarded SPE2D026F0105 to Eagle Pharmaceuticals, Inc (potential $186K).

Who is the incumbent on SPE2D026F0105?

Eagle Pharmaceuticals, Inc is the incumbent with $848K across 45 related awards in SCOUT’s public footprint. The current period of performance ends Apr 6, 2027.

When does Eagle Pharmaceuticals, Inc’s SPE2D026F0105 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 6, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on SPE2D026F0105 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Feb 26, 2026